MIP-1404

· Molecular Insight Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MIP-1404, covering 2016-03-30 to 2016-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology [Phase 2]

See pricing